-transparent.png){kind=logo}
Administration of cis-dichlorodiammineplatinum(II) may be associated with a number of serious side effects, including nephrotoxicity, gastroeintestinal side effects (nausea, vomiting, and diarrhea), myelosuppression, and occasional transient elevations in liver function tests. In addition, ototoxicity (tinnitus and hearing loss), anaphylactic reactions, peripheral neuropathies, and hypomagnesemia with resulting tetany may also be encountered. The toxic potential of this new agent necessitates careful clinical monitoring during treatment.
Related Publications
D D Von Hoff, and
R Schilsky, and
C M Reichert, and
R L Reddick, and
M Rozencweig, and
R C Young, and
F M Muggia
January 1985,
Eksperimental'naia onkologiia,
D D Von Hoff, and
R Schilsky, and
C M Reichert, and
R L Reddick, and
M Rozencweig, and
R C Young, and
F M Muggia
August 1971,
Toxicology and applied pharmacology,
D D Von Hoff, and
R Schilsky, and
C M Reichert, and
R L Reddick, and
M Rozencweig, and
R C Young, and
F M Muggia
January 1975,
Cancer chemotherapy reports,
D D Von Hoff, and
R Schilsky, and
C M Reichert, and
R L Reddick, and
M Rozencweig, and
R C Young, and
F M Muggia
January 1979,
Cancer treatment reports,
D D Von Hoff, and
R Schilsky, and
C M Reichert, and
R L Reddick, and
M Rozencweig, and
R C Young, and
F M Muggia
April 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
D D Von Hoff, and
R Schilsky, and
C M Reichert, and
R L Reddick, and
M Rozencweig, and
R C Young, and
F M Muggia
August 1988,
Journal of cell science,
D D Von Hoff, and
R Schilsky, and
C M Reichert, and
R L Reddick, and
M Rozencweig, and
R C Young, and
F M Muggia
January 1979,
Cancer treatment reports,
D D Von Hoff, and
R Schilsky, and
C M Reichert, and
R L Reddick, and
M Rozencweig, and
R C Young, and
F M Muggia
January 1979,
Cancer treatment reports,
D D Von Hoff, and
R Schilsky, and
C M Reichert, and
R L Reddick, and
M Rozencweig, and
R C Young, and
F M Muggia
July 1976,
Cancer treatment reports,
D D Von Hoff, and
R Schilsky, and
C M Reichert, and
R L Reddick, and
M Rozencweig, and
R C Young, and
F M Muggia
February 1978,
Cancer treatment reports,
